PYXS   $1.47  -4.55% Market Closed After Close 1.47 0.0

Pyxis Oncology, Inc.
Total Cash 155.72M
totalCashPerShare 2.642
EBITDA -63.16M
Total Debt 20.87M
quickRatio 9.216
currentRatio 9.531
Total Revenue 16.15M
debtToEquity 12.293
Revenue/Share 0.327
ROA -0.21531
ROE -0.37581003
grossProfits
freeCashflow -14.91M
operatingCashflow -56.55M
earningsGrowth
revenueGrowth
grossMargins 0.97058
ebitdaMargins 0.0
operatingMargins -4.09247
profitMargins 0.0
enterpriseValue 102.10M
forwardPE -3.3781512
floatShares 38.74M
sharesOutstanding 59.42M
sharesShort 4.91M
sharesShortPriorMonth 3.77M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.55%
Short Ratio help_outline 9.55%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 2.882
Price To Book help_outline 1.39
earningsQuarterlyGrowth
netIncomeToCommon -59.20M
trailingEps -1.30%
forwardEps -1.19%
enterpriseToEbitda -1.62
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.31 3Q 2024
institutionsCount 115
lastUpdated Nov. 7, 2024, 6:55 a.m.